Table 7 Overall results for groups I and II
From: The role of URO17® in diagnosis and follow up of bladder cancer patients
Cystoscopy | Sensitivity | Specificity | PPV | NPV | Accuracy | ||||
|---|---|---|---|---|---|---|---|---|---|
Free of malignancy (n = 96) | Positive of malignancy (n = 53) | ||||||||
No. | % | No. | % | ||||||
Urinary URO17 | |||||||||
Negative | 71 | 74.0 | 1 | 1.9 | 98.11 | 73.96 | 67.53 | 98.61 | 82.55 |
Positive for malignancy | 25 | 26.0 | 52 | 98.1 | |||||
χ2 (P) | 71.029* (< 0.001*) | ||||||||
Urine cytology | |||||||||
Inflammatory | 67 | 69.8 | 9 | 17.0 | 83.02 | 69.79 | 60.27 | 88.16 | 74.50 |
Positive for malignancy | 29 | 30.2 | 44 | 83.0 | |||||
χ2 (P) | 38.110 (< 0.001*) | ||||||||